Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma
Lymph Node Excision
PC-RPLND remains critical in the management of patients with NSGCT. Patients found to have teratoma at PC-RPLND have a 10-year probability of freedom from recurrence of 80%. The size of the residual mass and IGCCCG risk classification were significant predictors of disease recurrence.